Agf Investments LLC Gilead Sciences, Inc. Transaction History

Agf Investments LLC

$1.09 Billion
Q3 2022

A detailed history of Agf Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Agf Investments LLC holds 26,933 shares of GILD stock, worth $2.43 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

26,933

Previous 14,748 82.62%

Holding current value

$2.43 Million

Previous $912,000 82.13%

% of portfolio

0.15%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $725,494 - $828,701	12,185 Added 82.62%	26,933 $1.66 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $55,411 - $62,409	960 Added 6.96%	14,748 $912,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $103,213 - $129,337	1,782 Added 14.84%	13,788 $820,000
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $185,427 - $210,463	2,858 Added 31.24%	12,006 $872,000
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $36,958 - $39,874	-546 Reduced 5.63%	9,148 $639,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $53,695 - $58,670	-846 Reduced 8.03%	9,694 $668,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $163,800 - $186,895	-2,730 Reduced 20.57%	10,540 $681,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $564,234 - $642,918	-9,960 Reduced 42.88%	13,270 $773,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $118,673 - $149,210	-1,911 Reduced 7.6%	23,230 $1.47 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $337,032 - $391,356	-4,659 Reduced 15.63%	25,141 $1.93 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $1.05 Million - $1.34 Million	-16,700 Reduced 35.91%	29,800 $2.23 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $239,393 - $263,325	3,885 Added 9.12%	46,500 $3.02 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $25,754 - $28,428	-412 Reduced 0.96%	42,615 $2.7 Million
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $152,880 - $171,437	2,471 Added 6.09%	43,027 $2.91 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $482,293 - $540,295	7,713 Added 23.48%	40,556 $2.64 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $18,888 - $24,648	312 Added 0.96%	32,843 $2.05 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $6,914 - $7,655	97 Added 0.3%	32,531 $2.51 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $171,285 - $189,644	-2,403 Reduced 6.9%	32,434 $2.53 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $1.24 Million - $1.45 Million	19,123 Added 121.69%	34,837 $2.47 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $1.14 Million - $1.39 Million	15,651 Added 24842.86%	15,714 $1.19 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $4,542 - $5,384	63	63 $5,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.

Account

Agf Investments LLC Gilead Sciences, Inc. Transaction History